TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05696626 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06565780 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05610527 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05614362 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05614362 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05138029 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05138029 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06431139 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06451536 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05071482 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05071482 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06536491 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03770663 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT04685135 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06075758 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06075758 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06075758 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06075758 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05690607 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05408715 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT05582993 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05542147 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT05542147 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study NCT06585410 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05715229 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05484011 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05125458 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05125458 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06578247 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06119685 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05599737 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04234867 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06267053 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05554354 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05554354 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05554354 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06650579 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06650579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06292351 — Predictive Biomarker (PRD): HLA-DMB mRNA
Genes: HLA-DMB; DMB; RING7
Study NCT06235216 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT05118854 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00001020 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05198063 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06328673 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT05072912 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT06299124 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06299124 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06299124 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06299124 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05091541 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05091541 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06445803 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06445803 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06324357 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06087367 — Predictive Biomarker (PRD): KCNH2 mRNA
Genes: KCNH2; ERG; ERG1; HERG
Study NCT05967572 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05624658 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05207657 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05207657 — Predictive Biomarker (PRD): NCF1 mRNA
Genes: NCF1; NOXO2; SH3PXD1A
Study NCT01931306 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01931306 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04761640 — Predictive Biomarker (PRD): PNN mRNA
Genes: PNN; DRS; MEMA
Study NCT06590857 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06590857 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04753840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06677203 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00000721 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000721 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT01845506 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05355740 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06267144 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06137586 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05671068 — Predictive Biomarker (PRD): SGCE mRNA
Genes: SGCE; ESG; UNQ433/PRO840
Study NCT05450965 — Predictive Biomarker (PRD): PLK1 mRNA
Genes: PLK1; PLK
Study NCT05557942 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05626400 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04486378 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05786417 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT06069622 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT05510050 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05442684 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06232044 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06777290 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06047080 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05892926 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05892926 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06540391 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06317649 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03259633 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06531824 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06531824 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05062044 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05852964 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05852964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05852964 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05852964 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study NCT05852964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05852964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05852964 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT05852964 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05836220 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04692675 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06103266 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT06017258 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT05144555 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05638295 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06648473 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04890236 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04661683 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04819100 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04625049 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT06084481 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06084481 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06084481 — Safety Biomarker (SAF): Vitamin K-dependent protein C
Genes: PROC
Study NCT06084481 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06084481 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06235983 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06725173 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT05245240 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00000758 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06727136 — Predictive Biomarker (PRD): TBP mRNA
Genes: TBP; GTF2D1; TF2D; TFIID
Study NCT05514054 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05514054 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04643041 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06282315 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05152147 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05524584 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05524584 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05966441 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05966441 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06295679 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06191952 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04997174 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT05798221 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05303129 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05303129 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05303129 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06657131 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05401500 — Predictive Biomarker (PRD): ACTA2 mRNA
Genes: ACTA2; ACTSA; ACTVS; GIG46
Study NCT06608693 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04210141 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT05735873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06595420 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06595420 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT06360094 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06085664 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06085664 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT05757791 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06610448 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06610747 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06668961 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT06672445 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study NCT06058793 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT06676540 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06602258 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06677710 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06675357 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05531981 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05263557 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06632977 — Predictive Biomarker (PRD): EZH2
Genes: EZH1; ENX-1; KMT6; KMT6A
Study NCT06632977 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06679946 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05432492 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05327010 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05327010 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05327010 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05850234 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06757855 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06757855 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study NCT06758128 — Predictive Biomarker (PRD): HCLS1 mRNA
Genes: HCLS1; HS1
Study NCT05063552 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06188208 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT06634004 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT06116071 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study NCT06712069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06726148 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06726148 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06726148 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06726148 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06719661 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06730633 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05225870 — Predictive Biomarker (PRD): CTTN mRNA
Genes: CTTN; EMS1
Study NCT05743361 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06578286 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06106802 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06106802 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06526299 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04280523 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT04280523 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05424627 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05424627 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT06185660 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06185660 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05034705 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04947800 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04947800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06760819 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06766604 — Predictive Biomarker (PRD): GDF9 mRNA
Genes: GDF9
Study NCT05440110 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT00808197 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06343766 — Predictive Biomarker (PRD): ENAM mRNA
Genes: ENAM
Study NCT06343766 — Predictive Biomarker (PRD): KLK4 mRNA
Genes: KLK4; EMSP1; PRSS17; PSTS
Study NCT06343766 — Predictive Biomarker (PRD): TUFT1 mRNA
Genes: TUFT1
Study NCT05184582 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05236608 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05236608 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05236608 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06772415 — Predictive Biomarker (PRD): KIF18A mRNA
Genes: KIF18A; OK/SW-cl.108
Study NCT02546102 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05350163 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04698200 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06316427 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05159999 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04276233 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT06224452 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05947864 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05110196 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06585969 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06585969 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06669650 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT06669650 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04530383 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06227897 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04787107 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06068985 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06068985 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06363773 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06052306 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04813328 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06159179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06159179 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT06159179 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06159179 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04797780 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study NCT04946916 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04946916 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06578169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01396850 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06196775 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05709834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04887324 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05674422 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05735093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05735093 — Predictive Biomarker (PRD): TNFRSF6B
Genes: DcR3; DCR3; TR6; M68
Study NCT06117423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05161923 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05556863 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study NCT05936190 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05160051 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05781698 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05781698 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT05304234 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00031070 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06446843 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06669117 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00000649 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06440005 — Predictive Biomarker (PRD): TM4SF1 mRNA
Genes: TM4SF1; M3S1; TAAL6
Study NCT06352957 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT06335433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06726330 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06726330 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06726330 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study NCT06726330 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT06727162 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06726096 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05917106 — Monitoring Biomarker (MOI): Circulating tumor DNA